This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of human Platelet Lysate (HPL) in subjects with Lateral Epicondylitis (Tennis Elbow). The study is being conducted in 2 centers in India. The primary end points are Visual Analog Score (VAS) and Patient rated tennis elbow evaluation (PRTEE) score. The secondary endpoint is improvement in ultrasonography form randomization to End of study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Subjects will receive one injection of Autologous Human Platelet Lysate in the lateral epicondyle space
Subjects will receive one injection of Corticosteroid in the lateral epicondyle space
Kasiak Research Pvt Ltd
Thane, Maharashtra, India
RECRUITINGChange in Visual Analog Score (VAS)
Time frame: Day 0, Month 1, Month 2, End of Study - Month 3
Change in Ultrasonography of the lateral epicondyle region from Baseline to End of study at Month 3
Time frame: Day 0, End of study - Month 3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.